Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:36 PM
Ignite Modification Date:
2025-12-24 @ 9:36 PM
NCT ID:
NCT07243132
Eligibility Criteria:
Inclusion Criteria:
* Patient over 18 years old
* Patients alive after more than three years from diagnosis with stage IV or Stage III NSCLC or SCLC, not treated with cytotoxic chemotherapy at the time of inclusion (the patient may be undergoing imunotherapy, targeted therapy or surveillance).
* Patients covered by the French National Health Insurance program or with thirdparty-payer health insurance
Exclusion Criteria:
* Difficulties for understanding French
* Patients undergoing treatment with cytotoxic chemotherapy
* Patients under legal guardianship, under curatorship or tutorship
* Insufficient cognitive capacity to answer questions
* Inability to obtain data collection (lost to follow-up, patient's refusal for data collection)
* Patients refusing the collection of their data (an information sheet will be provided)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07243132
Study Brief:
Protocol Section:
NCT07243132